David Shaw’s LENZ Therapeutics LENZ Stock Holding History
Bought
Maintained
Sold
Other funds holding LENZ
7IH
David Shaw's LENZ Position: Q3 2026 in Review
David Shaw opened a new position in LENZ Therapeutics (LENZ) in Q3 2026: 187,027 shares worth $718K. The stake represents ﹤0.01% of the portfolio and ranks #4040 among its holdings. This is a return to the name: David Shaw previously reported a position in LENZ as recently as Q4 2024.
David Shaw first reported a position in LENZ in Q3 2021 and has held it in 9 quarters since. The position peaked at $876K in Q3 2021. 138 funds tracked by Wall St. Rank hold LENZ as of Q3 2026.
- David Shaw held 187,027 shares of LENZ Therapeutics worth $718K as of Q3 2026.
- LENZ Therapeutics was a new David Shaw position in Q3 2026.
- LENZ Therapeutics made up ﹤0.01% of David Shaw's portfolio in Q3 2026, its #4040 holding.
- David Shaw first reported a position in LENZ Therapeutics in Q3 2021 and has held it in 9 quarters since.
- David Shaw's LENZ Therapeutics position peaked at $876K in Q3 2021.
- 138 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q3 2026.
Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.